Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery

NCT01643252 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped This study was withdrawn for business reasons.

Conditions

Corneal Ectasia

Interventions

DRUG: riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system
DRUG: placebo: 0.0% riboflavin ophthalmic solution with the KXL system

Sponsor

Glaukos Corporation